Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES survey

Zhejia Tian, Samira Soltani, View ORCID ProfileJohann Bauersachs, Kai Schmidt-Ott, View ORCID ProfileAnette Melk, View ORCID ProfileBernhard MW Schmidt
doi: https://doi.org/10.1101/2024.03.04.24303751
Zhejia Tian
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samira Soltani
3Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johann Bauersachs
3Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johann Bauersachs
Kai Schmidt-Ott
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anette Melk
2Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anette Melk
Bernhard MW Schmidt
1Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
MD, SM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernhard MW Schmidt
  • For correspondence: schmidt.bernhard{at}mh-hannover.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined chronic health condition from American Heart Association. We assessed the prevalence of CKM syndrome stages 0-2, which have not yet progressed to cardiovascular disease (stage 3-4) with trends analysis over the past two decades.

Methods We used cross-sectional data provided by National Health and Nutrition Examination Survey. including non-pregnant participants aged 18 or older between 1999 and 2020. Weighted prevalence was analyzed over the course of the past 20 years and by population subgroup (including age, sex, and race/ethnicity).

Results A total of 32848 US adults were included in our study (weighted mean age, 47.3 years; women, 51.3%). 7.9% of US adults were at stage 0 without any CKM risk factors, with 64% of this subgroup being female. 18.3% of US adults were classified as stage 1 with issues related to excess or dysfunctional adiposity without other metabolic risk factors or chronic kidney disease (CKD). More than half of the US adults (56.5%) exhibited either metabolic risk factors, CKD, or both (stage 2). Between 1999 and 2020, the CKM features increased with decreasing prevalence of stage 0 (P for trends =0.0018), not only in females but also in males.

Conclusions Our findings illustrate an exceptionally high and increasing prevalence of CKM syndrome among US adults. This emphasizes the importance of comprehensive preventive strategies targeting the life style of large parts of the population. Moreover, further risk assessment should be implemented into stage 2 cohort to define patients with exceptional cardiovascular risk.

What is new?

  • CKM syndrome is a common chronic health condition in the general population. However, the prevalence of different CKM stages using real-world data has not been reported within the general population or its subgroups.

  • The prevalence of CKM syndrome was increasing over the past two decades. The majority of US adults were classified as stage 2.

  • A specific population remained undefined according to the current detailed definition of each CKM syndrome stage.

What are the clinical implications?

  • The high and increasing prevalence of CKM syndrome necessitates more precise preventive strategies, tailored to different target groups with consideration of age-, sex-, and gender-disparities.

  • Given that approximately half of the study population fell into stage 2 with a wide spectrum of risk factors, it is imperative to identify patients with exceptionally high risk through additional risk assessments. This approach would facilitate the implementation of intensified treatment measures aimed at preventing the progression to cardiovascular disease (CKM syndrome stages 3-4).

Competing Interest Statement

SS received honoraria from AstraZeneca for lectures and consulting and from KelCon for lectures, not related to this article.. JB received honoraria for lectures/consulting from Novartis, Vifor, Bayer, Pfizer, Boehringer Ingelheim, AstraZeneca, Cardior, CVRx, BMS, Amgen, Corvia, Norgine, Edwards, Roche not related to this article; and research support for the department from Zoll, CVRx, Abiomed, Norgine, Roche, not related to this article. KSO received lecture fees and honoraria from Boehringer Ingelheim, Astrazeneca, Bayer, Vifor, Alexion, Novartis, BioPorto Diagnostics and Abionyx, not related to this article. BMWS received lecture fees and honoraria from ADVITOS, Amgen, Bayer Vital, Berlin Chemie-Menarini, CytoSorbents, Daichii Sankyo, Miltenyi, Pocard, not related to this article.

Clinical Trial

this is not a clinical trial.

Funding Statement

There is no funding source in this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study procedures are approved by the National Center for Health Statistics Research Ethics Review Board. The Hannover Medical School Institutional Review Board exempted the present study due to deidentified data.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

NHANES data are available from the NHANES web page. The R code of the analysis is available from the authors on reasonable request.

  • Abbreviations and Acronyms

    BMI
    Body mass index
    CKD
    Chronic kidney disease
    CKM
    syndrome Cardiovascular-kidney-metabolic syndrome
    CVD
    Cardiovascular disease
    eGFR
    Estimated glomerular filtration rate
    MetS
    Metabolic syndrome
    NHANES
    National Health and Nutrition Examination Survey
    UACR
    Urinary albumin to creatinine ratio
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted March 06, 2024.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES survey
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES survey
    Zhejia Tian, Samira Soltani, Johann Bauersachs, Kai Schmidt-Ott, Anette Melk, Bernhard MW Schmidt
    medRxiv 2024.03.04.24303751; doi: https://doi.org/10.1101/2024.03.04.24303751
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    High Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome Among US Adults From 1999-2020 - An analysis of the NHANES survey
    Zhejia Tian, Samira Soltani, Johann Bauersachs, Kai Schmidt-Ott, Anette Melk, Bernhard MW Schmidt
    medRxiv 2024.03.04.24303751; doi: https://doi.org/10.1101/2024.03.04.24303751

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)